ACTIVE

Popelin Apotheken

Export PDF
Financial year 2025 · closed on 31/12/2025
Net result
-191,8 k €
-107.8% YoY
Revenue
152,2 M €
+2.9% YoY
Equity
4,1 M €
-4.5% YoY
Workforce
361,8 ETP
-20.8% YoY

What does Popelin Apotheken do?

Popelin Apotheken is a Private limited company incorporated in 2024. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Anderlecht. It employs on average 361,8 ETP workers (FTE).

Legal situation
● Normal situation
BCE/KBO no. / VAT
BE 1004.967.609
Incorporation
19/01/2024
Legal form
Private limited company
Registered office
Square Marie Curie 30
1070 Anderlecht · BruxellesSee on map
Contributed capital
7 623 818,47 €
Latest accounts
31/12/2025
Average workforce
361,8 ETP
Activities (NACE)
46460Wholesale of pharmaceutical goods· main46460Wholesale of pharmaceutical goods47730Dispensing chemist in specialised stores47730Dispensing chemist in specialised stores21201Manufacture of pharmaceutical preparations21201Manufacture of pharmaceutical preparations+4
Joint committees (2)
  • 313
  • 321
Signals
Positive cashflowPositive EBITDAHealthy social debtsHigh revenue
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 2 financial years

20252024
Income statement
Revenue152,2 M €147,9 M €
EBITDA4,6 M €5 M €
Operating result517 k €3,6 M €
Net result-191,8 k €2,5 M €
Balance sheet
Equity4,1 M €4,3 M €
Total assets51,2 M €46,4 M €
Cash4,6 M €752,8 k €
Debts43,8 M €41,9 M €
Other
Workforce361,8 ETP457,0 ETP
Estimate

Indicative valuation

As an indication, this company is worth

between 10 M€ and 25 M€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 6 ended

Active mandates

Geert Reyniers

Director · since 28 février 2025 · until 28 février 2030

Active

Ended mandates

Geert Reyniers

Director · since 28 février 2025

Ended
DEPRINCE

Director · since 29 mars 2024 · until 28 février 2025 · 0404.023.905

Represented by Leo Deprince

Ended
Hilde De Wolf

Director · since 29 mars 2024 · until 28 février 2025

Ended
J & L

Managing director · since 29 mars 2024 · until 28 février 2025 · 0781.714.684

Represented by Jan Kuyps

Ended
At this address

Other companies at this address

CompanyCBE no.
Apoteek Jespers - Cuijpers● Active
0440.256.175
APOTEEK P. Sergeant● Active
0454.105.203
APOTHEEK VANDYCK● Active
0458.570.666
APOTHEEK VUNCKX-PEETERS● Active
0897.964.137
DE ZEVEN HOEKEN● Active
0461.480.369
DLA● Active
0639.768.151
Goed Aalter● Active
0808.051.471
Multipharma● Active
0866.855.346
MULTIPHARMA GROUP● Active
0401.995.516
Office des sociétés coopératives de grossistes pharmaceutiques et de pharmacies - Vereniging van coöperatieve vennootschappen van farmaceutische groothandelaars en apotheken● Active
0406.518.090
TALPA FARMA● Active
0686.929.353
Annual accounts

Full financial information

20252024
Type of accountFull modelFull model
Start of the financial year01/01/202519/01/2024
Closing of the financial year31/12/202531/12/2024
Length of the financial year12 months12 months
Filing date25/06/202612/08/2025
General meeting11/06/202623/06/2025
Currency of the financial yearEUREUR
NBB quality labelSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

2 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Full model31/12/202511/06/202625/06/2026DutchPDF
Full model31/12/202423/06/202512/08/2025DutchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 10 M€ and 25 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 6 ended

Active mandates

Geert Reyniers

Director · since 28 février 2025 · until 28 février 2030

Active

Ended mandates

Geert Reyniers

Director · since 28 février 2025

Ended
DEPRINCE

Director · since 29 mars 2024 · until 28 février 2025 · 0404.023.905

Represented by Leo Deprince

Ended
Hilde De Wolf

Director · since 29 mars 2024 · until 28 février 2025

Ended
J & L

Managing director · since 29 mars 2024 · until 28 février 2025 · 0781.714.684

Represented by Jan Kuyps

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Other30/06/2026
    1004.967.609
    PDF
  • Mandates03/10/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates11/03/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Registered office06/03/2025
    BENAMING - MAATSCHAPPELIJKE ZETEL
    PDF
  • Mandates21/01/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other13/09/2024
    DIVERSEN
    PDF
  • Mandates10/06/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Restructuring17/04/2024
    KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-191,8 k €↓
  2. 2024
    Annual accounts 20242,5 M €
  3. 19/01/2024
    IncorporationPrivate limited company